Loading...
Health Disparities of Sexual Minority Patients Following Prostate Cancer Treatment: Results From the Restore-2 Study
Rosser, B.R. Simon Polter, Elizabeth J. Talley, Kristine M.C. Haggart, Ryan Wright, Morgan West, William Mitteldorf, Darryl Ross, Michael W. Konety, Badrinath R.
Rosser, B.R. Simon
Polter, Elizabeth J.
Talley, Kristine M.C.
Haggart, Ryan
Wright, Morgan
West, William
Mitteldorf, Darryl
Ross, Michael W.
Konety, Badrinath R.
Citations
Altmetric:
Genre
Journal article
Date
2022-02-04
Advisor
Committee member
Group
Department
Social and Behavioral Sciences
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.3389/fonc.2022.812117
Abstract
Purpose: The NIH has identified sexual and gender minority persons as a health disparity population but little is known about cancer outcomes in these populations. The purpose of this study was to identify disparities in sexual minority prostate cancer patient-reported outcomes, to examine within group differences, and to test for alternative explanations for identified differences. Materials and Methods: In 2019, we recruited 401 gay and bisexual prostate cancer patients into the Restore-2 study, a randomized controlled trial of rehabilitation program tailored for sexual minority men. Results: Compared to the normative (heterosexual) EPIC sample, participants had significantly worse urinary, bowel and hormonal function, better sexual function, and no difference on bother scores. They also had worse depression and overall mental health, and worse physical, social/family, functional, prostate specific and overall well-being quality of life outcomes. Across measures, no differences by age, gay versus bisexual orientation, race/ethnicity, and relationship status were observed. Those who had hormonal treatment had worse sexual and hormonal function than those who had radiation or surgery only. Those with a longer time since treatment had better urinary function. Differences remained when participants were matched to normative samples on cancer stage and time since treatment. Conclusions: This, the largest study of sexual minority prostate cancer patients to date, confirms health disparities in prostate cancer quality of life outcomes. Findings appear reliable and robust. To improve the clinical care of prostate cancer, it will be important to address the health disparities experienced by sexual minority prostate cancer patients.
Description
Citation
Rosser BRS, Polter EJ, Talley KMC, Wheldon CW, Haggart R, Wright M, West W, Mitteldorf D, Ross MW, Konety BR and Kohli N (2022) Health Disparities of Sexual Minority Patients Following Prostate Cancer Treatment: Results From the Restore-2 Study. Front. Oncol. 12:812117. doi: 10.3389/fonc.2022.812117
Citation to related work
Frontiers Media
Has part
Frontiers in Oncology, Vol. 12
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu